HBG2 and hepatocellular carcinoma: In conclusion, our study showed that in HBV-associated HCC patients with low levels of HBV-DNA undergoing curative hepatectomy, tumor factors and methemoglobin levels were associated with early recurrence, liver function blood biochemical parameters determined late recurrence, and antiviral therapy reduced early tumor recurrence and improved OS, resulting in long-term survival benefits for patients.